News

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29
Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut ...
Barchart on MSN17h
Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?
Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a ...
European Supermarket Magazine1d
Kenvue Top Boss Thibaut Mongon Steps Down, Kirk Perry Named Interim CEO
Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood
The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...